Hledat v komentářích
Investiční doporučení
Výsledky společností - ČR
Výsledky společností - Svět
Týdenní přehledy

Detail - články
UCB: Mature product windfalls boost 1H11 result

UCB: Mature product windfalls boost 1H11 result

1.8.2011 11:20

UCB reported excellent first half results, outperforming market expectations both at the top and bottom-line, driven by excellent product sales. Consequently, management narrowed the FY11 financial guidance towards the upper end of the previously-defined range. Although 2H11 will inevitably suffer from fierce generic erosion on mature products, we feel the targets are conservative and well achievable.

The first half update did not trigger any major updates to our FY11 sales or P&L forecasts. Most important changes are a small increase in REBITDA to € 698m (from € 691m), a decrease of € 50m in financial charges to € 136m, both contributing to an uplift of our FY11 core EPS estimate from € 1.75.sh to € 1.95/sh). We are ahead of the company’s guidance (revenue expected at € 3.1bn or more (from € 3.0bn to € 3.1bn previously), with REBITDA and core EPS at the upper end of the scales of respectively € 650-680m and € 1.6-€ 1.7) and expect that the consensus will see some soft increases as well.

While we are positive on UCB's mid to long-term prospects, we believe at current trading levels the market is pricing in the bright prospects of the company’s CVN products and drug development pipeline. Moreover, since the rally in May, spurred by take-over rumours, UCB’s share withstood the market turmoil, resulting in a year-to-date outperformance of 30% versus general indices and a substantial premium versus peers.

With no binary events expected in the coming period, we see limited downside risk from operations, but in thecurrent economic climate some investors may be tempted to take their profits. Overall, FY11 is still a transition year, with earnings expected to grow as of 2H12. We therefore advise investors to HOLD the stock with a target price of € 32/sh.

Nově na Patria.cz - obchodní signály na forexu podle technických indikátorů ADX, Williams R% a klouzavých průměrů!
Váš názor
Na tomto místě můžete zahájit diskusi. Zatím nebyl zadán žádný názor. Do diskuse mohou přispívat pouze přihlášení uživatelé (Přihlásit). Pokud nemáte účet, na který byste se mohli přihlásit, registrujte se zde.
Aktuální komentáře

Související komentáře
Nejčtenější zprávy dne
Nejčtenější zprávy týdne
Nejdiskutovanější zprávy týdne
Denní kalendář hlavních událostí
Anheuser-Busch InBev SA/NV/old (09/16 Q3)
Danske Bank A/S (09/16 Q3)
Goodyear Tire & Rubber Co/The (09/16 Q3, Bef-mkt)
Chevron Corp (09/16 Q3, Bef-mkt)
International Consolidated Airlines Group SA (09/16 Q3)
Novo Nordisk A/S (09/16 Q3, Bef-mkt)
Royal Bank of Scotland Group PLC (09/16 Q3)
Weyerhaeuser Co (09/16 Q3, Bef-mkt)
Xerox Corp (09/16 Q3, Bef-mkt)
1:30JP - CPI, y/y
6:45UBS Group AG (09/16 Q3)
7:00BNP Paribas SA (09/16 Q3)
7:30Linde AG (09/16 Q3)
7:30Sanofi (09/16 Q3)
7:30Skanska AB (09/16 Q3)
7:45Eni SpA (09/16 Q3)
8:00Electrolux AB (09/16 Q3)
8:00Hexagon AB (09/16 Q3)
8:00TOTAL SA (09/16 Q3)
12:30Newell Brands Inc (09/16 Q3)
13:00AbbVie Inc (09/16 Q3)
13:00AutoNation Inc (09/16 Q3)
13:00Hershey Co/The (09/16 Q3)
13:00Phillips 66 (09/16 Q3)
14:00DE - Harmonizovaný CPI, y/y
14:00Exxon Mobil Corp (09/16 Q3)
14:00Mastercard Inc (09/16 Q3)
14:30USA - HDP, q/q a
16:00USA - Index spotř. důvěry Mich. university